Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Effect of HER2 Activation on rhuMAb 2C4 (Pertuzumab) in Subjects With Advanced Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
CA125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women
- Status
- COMPLETED
- Phase
- NA
Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trial for Ovarian Cancer (OvaRex®)
- Status
- TERMINATED
- Phase
- PHASE3
Gefitinib in Treating Patients With Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
UCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
- Status
- COMPLETED
- Phase
- N/A
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- NA
Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer
- Status
- UNKNOWN
- Phase
- NA